Understanding iDose® TR: A Breakthrough in Glaucoma Treatment thumbnail

Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

Published en
1 min read


iDose® TR represents a revolutionary advancement in the treatment of glaucoma, providing a consistent and reliable option for managing intraocular pressure (IOP). In contrast to traditional eye drops that require daily administration, iDose® TR is a small, implantable device crafted to provide a controlled release of medication directly into the eye over an longer period. This cutting-edge approach reduces the burden of constant dosing, greatly enhancing patient adherence and overall treatment outcomes.

At Eye Center South, we are proud to offer iDose® TR as part of our holistic glaucoma care. The device is implanted during a simple and low-risk procedure, designed with your ease in mind. Once in place, it ensures a steady release of glaucoma medication, working to stabilize intraocular pressure and safeguarding your eyesight. Patients who find challenges in the demands of frequent eye drop use can find relief from this cutting-edge treatment.



Visit for more info At Eye Center South